UnipharDUB:UPR -0.65%82 EV-to-FCF is 33.22 as of Jun. 29, 2026, which is 26% above its 10-year median of 26.30. GuruFocus rates DUB:UPR with a GF Score™ of 82/100 and a GF Value™ of €3.64 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 75 Medical Distribution companies, Uniphar ranks worse than 72% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Uniphar's Enterprise Value is €1,515 Mil.
Uniphar's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €46 Mil. Therefore, Uniphar's EV-to-FCF for today is 33.22.
The historical rank and industry rank for Uniphar's EV-to-FCF or its related term are showing as below:
DUB:UPR'
s EV-to-FCF Range Over the Past 10 Years
Min: -22.22 Med: 26.3 Max: 63.53
Current: 33.22
During the past 10 years, the highest EV-to-FCF of Uniphar was 63.53. The lowest was -22.22. And the median was 26.30.
DUB:UPR's EV-to-FCF is ranked worse than 72% of 75
companies
in the Medical Distribution industry
Industry Median: 16.05
vs DUB:UPR: 33.22
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Uniphar's share price for today is €4.57.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uniphar's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.195.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Uniphar EV-to-FCF Related Terms
Uniphar EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Uniphar's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Uniphar's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uniphar EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Uniphar's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Uniphar's EV-to-FCF falls into.
Uniphar's current Enterprise Value is €1,515 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uniphar's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uniphar (DUB:UPR) has a EV-to-FCF of 33.22 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Uniphar and its competitors. This is 26% above median its historical median of 26.30. According to the industry distribution chart, Uniphar ranks #54 out of 75 companies in the Medical Distribution industry, placing it in the top 72%.
Is Uniphar's EV-to-FCF too high?
Uniphar's current EV-to-FCF of 33.22 is 26% above median its 10-year median of 26.30. The Medical Distribution industry median EV-to-FCF is 16.05. Uniphar's value of 33.22 is 107% above this industry median. Based on the distribution chart, Uniphar ranks #54 out of 75 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Uniphar has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Uniphar ranks #54 out of 75 companies for EV-to-FCF. This places Uniphar in the lower half of its industry. The industry median EV-to-FCF is 16.05. Uniphar's value of 33.22 is 107% above this benchmark. While the company's 10-year median is 26.30 vs. the industry median of 16.05, Uniphar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.05, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uniphar's current EV-to-FCF of 33.22 is 107% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Uniphar and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uniphar's current EV-to-FCF is 33.22, which is 26% above median its own 10-year median of 26.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.57 — trading 25.5% above its estimated fair value. The current EV-to-FCF is 33.22, which is 26% above median its 10-year median of 26.30 and 107% above the Medical Distribution industry median of 16.05. Uniphar's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current EV-to-FCF is 33.22 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uniphar (DUB:UPR) Overvalued in 2026?
Based on GuruFocus' analysis, Uniphar stock appears to be overvalued.
The current stock price of €4.57 is trading 25.5% above its estimated GF Value™ of €3.64.
GuruFocus considers Uniphar to be Modestly Overvalued.
Key valuation signals for DUB:UPR:
EV-to-FCF: 33.22 (26% above median its 10-year median of 26.30)
GF Value™: €3.64 vs. price of €4.57 (25.5% above fair value)
Industry Position: 107% above the Medical Distribution median (#54 of 75)
No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
82GF Score
Get the complete analysis for DUB:UPR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DUB:UPR has been successfully added to your 
